Dr. Orest Bohdan Bartoszyk, MD

Dr. Bartoszyk practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Bartoszyk's NPI, 1295726537, was assigned on November 4, 2005. Dr. Bartoszyk graduated from Rutgers New Jersey Medical School in 1979. Dr. Bartoszyk holds Maryland license D0039909.

Dr. Bartoszyk's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Bartoszyk's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Bartoszyk is also affiliated with MedStar St. Mary's Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Bartoszyk to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bartoszyk practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bartoszyk's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bartoszyk is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bartoszyk's licenses on file in 4 states: Maryland, New York, District of Columbia and New Jersey.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease and deep vein thrombosis (DVT) among the conditions Dr. Bartoszyk treats.

CMS data shows 3,171 Medicare services from Dr. Bartoszyk across 17 procedure codes in 2024, for 847 Medicare patients. Medicare paid $218,828 for them.

CMS counts 847 Medicare patients who saw Dr. Bartoszyk in 2024. The largest group is 65 to 74, with 340 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bartoszyk's median patient age at 64, with 51% women.

In 2024, Dr. Bartoszyk wrote 2,395 Medicare Part D claims for 402 patients. 86% of them were for generic drugs. CMS names the drug for 2,145 of them, across 42 drugs with 11 or more claims each, at $339,371 in total drug cost. In 2023, CMS named 1,642 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Bartoszyk for performance year 2024, reported as part of a group. Dr. Bartoszyk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bartoszyk as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Bartoszyk from 2 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $61.

Dmand AI lists 1 award for Dr. Bartoszyk.

Dr. Bartoszyk graduated from Rutgers New Jersey Medical School in 1979. Dr. Bartoszyk is a member of ACC.

Dr. Bartoszyk is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.